- Adverse events occurred during 3 months after endobronchial valve treatment.
| Adverse events | From the day of the procedure to 45 days afterward | Between the 45 days after the procedure and the 3-month follow-up date |
|---|---|---|
| Respiratory | ||
| Cough | 12 (31.6) | 8 (21.1) |
| Increase in sputum production | 10 (26.3) | 6 (15.8) |
| Chest discomfort | 7 (18.4) | 4 (10.5) |
| Chest pain | 1 (2.6) | 0 (0.0) |
| Upper respiratory tract infection | 1 (2.6) | 0 (0.0) |
| Fever | 0 (0.0) | 1 (2.6) |
| Pneumonia | 0 (0.0) | 1 (2.6) |
| Non-Respiratory | ||
| Acute urinary retention | 2 (5.3) | 0 (0.0) |
| Atrial fibrillation | 1 (2.6) | 0 (0.0) |
| Hiatus hernia | 0 (0.0) | 1 (2.6) |